Navigation Links
March is National Colorectal Cancer Awareness Month: Do You Know What Your Screening Options Are?
Date:3/6/2009

Prevention through screening for colorectal cancer and removal of precancerous polyps among key factors in saving lives

Oak Brook, Ill., March 6 /PRNewswire-USNewswire/ -- Colorectal cancer, also referred to as colon cancer, is one of the most preventable cancers. Recent statistics show that the incidence (the rate at which new cancers are diagnosed) and death rates from colorectal cancer are declining, in part due to prevention through screening and removal of precancerous polyps (growths in the colon that can turn into cancer). Colorectal cancer screening has been in the news a lot in the past few months, from studies about new technologies to updated screening recommendations; patients may be left wondering which screening method is best for them. March is National Colorectal Cancer Awareness Month and this year the American Society for Gastrointestinal Endoscopy (ASGE), which represents the specialists in colorectal cancer screening, is educating patients about the recommended screening methods.

"The good news is that death rates are declining from colorectal cancer. The bad news is that only about half of those who should be screened are doing so," said John L. Petrini, MD, FASGE, president of the American Society for Gastrointestinal Endoscopy. "Age is the most important risk factor for colorectal cancer. ASGE guidelines recommend screening begin at age 50 for men and women at average risk who have no symptoms. Some people may need to be screened earlier if there is a family history of the disease. It's important to talk to your doctor about an appropriate screening schedule. Ask questions and work with your doctor to determine the screening method that is best for you, as each screening option has appropriate applications and limitations."

To learn more about colorectal cancer prevention, log on to the ASGE's colorectal cancer awareness Web site '/>"/>

SOURCE American Society for Gastrointestinal Endoscopy
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Orchid Cellmark to Announce Fourth Quarter and Year-End 2008 Financial Results on March 16, 2009
2. eDiets.com(R) to Report Fourth Quarter and Year End 2008 Results on Monday, March 16, 2009
3. Photo: March Forth Into Spring with a Healthy Approach to Diet and Exercise
4. SCOLR Pharma, Inc. Schedules Fourth Quarter 2008 Financial Results Conference Call for March 11, 2009 at 11:30 A.M. Eastern
5. BurrellesLuce VP Johna Burke to Be Featured Presenter For PRSA's March 9th Free Webinar on 'Smart Measurement'
6. Medifast, Inc. to Announce Fourth Quarter and Fiscal Year 2008 Financial Results on Thursday, March 12, 2009
7. Arena Pharmaceuticals to Report Fourth Quarter and Full Year 2008 Financial Results and to Host Conference Call and Webcast on Thursday, March 12, 2009
8. Journal Chest: March news briefs
9. On March 4, 2009, The United States Supreme Court Rejected the Rationale Behind Michigans Drug Product Liability Law
10. National Multiple Sclerosis(MS) Awareness Week is March 15-21
11. AMERIGROUP Corporation to Present at the Barclays Capital Global Healthcare Conference on March 10

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)... promotes self-assurance, research finds , ...r may have been right when she told you to sit up ...could make you feel more confident about your thou...p straight gives a good impression to other people...chology professor at Ohio State University, said i...
(Date:11/8/2009)...ire-USNewswire/ -- Speaker Nancy Pelosi and Democr... House passage of H.R. 3962, the Affordable Health...of 220 to 215. Below are the Speaker,s opening re...ceived a call from the President of the United Sta...ctory for the American people. I thank the Preside...
(Date:11/8/2009)...drying of biopharmaceuticals to be available at th... , Toronto, ON (PRWEB) Nov... of Therapure Biopharma Inc. today announced that ...le pharmaceutical grade freeze dryer and expects t...ion) available for contract manufacturing of bioph...
(Date:11/8/2009)... the battle is won," said Dr. Charmaine Yoest. ,...In a vote of 240-194, the Stupak-Ellsworth-Pitts-K...bit abortion mandates and funding in HR 3962 passe...ife Action President and CEO Dr. Charmaine Yoest s...or the pro-life Americans across this country who ...
(Date:11/8/2009)... H.R. 3961 to Secure the Stability of Medicare ,...tement Attributable to: J. James Rohack, M.D., Pre... http://www.newscom.com/cgi-bin/prnh/20081209/AM...House health reform bill, which will help improve ...calls for swift passage of H.R. 3961 to secure the...
Breaking Medicine News(10 mins):Health News:Good Posture May Inspire Confidence 2Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2
...ame of a Class 10 correspondence course student in...iled to do, an official said Saturday//. The ...d 22 students of various private and government hi...at had three others with the same score. The boy h...
...sights about how a bacterium uses different recept...a are sensitive to minute changes in environments ...of 1 drop in a pool of 1,000 drops. New Corn...perative lattice on a bacterium's surface to ampli...
... essential for proper embryo development and disor...h defects such as cleft palate, spina bifida, repo...ffort of the University of Colorado, Health Scienc...Critical for Downregulation of E-Cadherin During M...
...announced a warning on the usage of Triaminic vapo...serious effects //they could have if accidentally ...h authorities have explained that life-threatening...ised as a cough suppressant for kids 2 years of ag...
...fter eating (traditionally called European siesta)... happening due to changes in glucose levels//. ...y in humans and as well as in animals become switc...sed from the neurons, whose action is focused on t...
...er treatment drug has proved so well in the drug t...ght be made //available to patients in the late st...the regulators. It is speculated that Europe... claim that unlike Roche's $1.8bn-a-year drug, Her...
Other Medicine News:Health News:Study Highlights How Bacteria Respond To Changes In Environment 2Health News:GSK’s New Anticancer Drug A Huge Success In Drug trail 2
(Date:11/6/2009)...PRNewswire-FirstCall/ -- Caraco Pharmaceutical Lab...torolac tromethamine ophthalmic solution, 0.5% fol...Administration (FDA) for Sun Pharma,s Abbreviated ...4; ophthalmic solution on the first day following ...herapeutically equivalent to Acular® Ophthalm...
(Date:11/6/2009)...6 America,s Specialty M...up of mid-market and smaller innovator pharmaceuti... 3962, the "Affordable Health Care for America Act...hese smaller companies fear that the cumulative ef...der their efforts to bring new medicines to market...
(Date:11/6/2009)... Nov. 6 Facet Solutions, Inc. anno... of Archus Orthopedics. The acquisition creates an...gs, intellectual property and clinical experience ...or patients suffering from lumbar spinal stenosis,...ff Pardo. "This consolidation further strengthens...
Breaking Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution 2Statement of America's Specialty Medicines Companies On House Health Care Bill (H.R. 3962) 2Facet Solutions Acquires Archus Orthopedics 2Insulet Corporation to Present at Upcoming Investor Conferences 53953 1Insulet Corporation to Present at Upcoming Investor Conferences 53953 2Garry OGrady Appointed Senior Vice President and General Manager of Pharmaceutical Institute 53951 1Garry OGrady Appointed Senior Vice President and General Manager of Pharmaceutical Institute 53951 2Delays in UK child brain tumor diagnosis 53949 1Delays in UK child brain tumor diagnosis 53949 2
...6 Pacira Pharmaceuticals, Inc., an,acute care spe...t enrollment,has been completed in two pivotal Pha...ficacy of a single intraoperative administration o...operative analgesia. , Results from the studie...ty (TKA) are expected to provide the primary clini...
...Micromet, Inc.,(Nasdaq: MITI ), a biopharmaceuti...es for the treatment of cancer, inflammation and a...ts anticipated for the year 2009. , Micromet i...velopment,programs at the following events: , ...ical BiTE antibodies at,the American Association f...
Other Medicine Technology:Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 3Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 5
... disease ELISA products make us a leader in this f...egration into the busy laboratory, our Infectious ...ty and run-to-run consistency. Our Infectious Dise...for a wide range of serological assays including T...
... disease ELISA products make us a leader in this f...egration into the busy laboratory, our Infectious ...ty and run-to-run consistency. Our Infectious Dise...for a wide range of serological assays including T...
... disease ELISA products make us a leader in this f...egration into the busy laboratory, our Infectious ...ty and run-to-run consistency. Our Infectious Dise...for a wide range of serological assays including T...
Giardia lamblia II EIA
Medicine Products: